Endotoxin challenge causes a proinflammatory state in obstructive jaundice

Journal of Investigative Surgery

Volumn 17, Issue 3, 2004, Pages 119-126

  Yorganci, Kaya ^a,b   Baykal, Ataç ^a   Kologlu, Murat ^a   Saribaş, Murat ^a   Hascelik, Gülsen ^a   Sayek, Iskender ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Cellular immunity; Endotoxemia; Immune suppression; Interleukin 10; Interleukin 2; Obstructive jaundice; Tumor necrosis factor

Indexed keywords

ENDOTOXIN; INTERLEUKIN 10; INTERLEUKIN 2; LIPOPOLYSACCHARIDE; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASSAY; BILE DUCT LIGATION; CELLULAR IMMUNITY; COMMON BILE DUCT; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTOXEMIA; FEMALE; IMMUNE DEFICIENCY; INFLAMMATION; MALE; NONHUMAN; OBSTRUCTIVE JAUNDICE; PRIORITY JOURNAL; PROVOCATION TEST; RAT;

ANIMALS; ENDOTOXINS; FEMALE; INTERLEUKIN-10; INTERLEUKIN-2; JAUNDICE, OBSTRUCTIVE; MALE; MODELS, ANIMAL; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 3042856277     PISSN: 08941939     EISSN: None     Source Type: Journal    
DOI: 10.1080/08941930490446892     Document Type: Article

References (39)

1. Cainzos M, Alcalde JA, Potel J, Puente JL. Hyperbilirubinemia, jaundice and anergy. Hepato-Gastroenterology. 1992;39:330-332.
2. Regan MC, Keane RM, Little D, Bouchier-Hayes D. Postoperative immunological function and jaundice. Br J Surg. 1994;81:271-273.
3. Scott-Conner CE, Grogan JB. The pathophysiology of biliary obstruction and its effect on phagocytic and immune function. J Surg Res. 1994;57:316-336.
4. Armstorng CP, Dixom JM, Taylor TV, Davies GC. Surgical experience of deeply jaundiced patients with bile duct obstruction. Br J Surg. 1984;71:234-238.
5. Trede M, Schwall G. The complications of pancreatectomy. Ann Surg. 1988;207:39-47.
6. Greve JW, Gouma DJ, Soeters PB, Buurman WA. Suppression of cellular immunity in obstructive jaundice caused by endotoxin. A study with germfree rats. Gastroenterology 1990;98:478-485.
7. Clements WDB, Erwin P, McCaigue MD, Halliday I, Barclay GR, Rowlands BJ. Conclusive evidence of endotoxaemia in biliary obstruction. Gut. 1998;42:293-299.
8. Kimmings AN, vanDeventer SJ, Obertop H, Rauws EA, Huibregtse K, Gouma DJ. Endotoxin, cytokines, and endotoxin binding proteins in obstructive jaundice and after preoperative biliary drainage. Gut. 2000;46:725-731.
9. Roughneen PT, Kumar SC, Pellis NR, Rowlands BJ. Endotoxaemia and cholestasis. Surg Gynaecol Obstet. 1988;167:205-210.
10. Bemelmans MHA, Greve JW, Gouma DJ, Buurman WA. Cytokines tumor necrosis factor and interleukin-6 in experimental biliary obstruction in mice. Hepatology. 1992;15:1132-1136.
11. Kennedy JA, Lewis H, Clements WDB, Kirk SJ, Campbell G, Halliday MI, Rowlands BJ. Kupffer cell blockade, tumor necrosis factor secretion and survival following endotoxin challenge in experimental biliary obstruction. Br J Surg. 1999;86:1410-1414.
12. Selzman CH, Shames BD, Miller SA, Pulido EJ, Meng X, McIntyre RC, Harken AH. Therapeutic implications of interleukin-10 in surgical disease. Shock. 1998;10:309-318.
13. Knolle P, Schlaak J, Uhrig A, Kempf P, Büschenfelde KHM, Gerken G. Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge. J Hepatol. 1995;22:226-229.
14. Curran RD, Billiar TR, West MA, Benz BG, Simmons RL. Effect of interleukin 2 on Kupffer cell activation. Arch Surg. 1988;123:1373-1378.
15. Wong LK, Ridinger DN, Bandhauer M, Ward JH, Samlowski WE, Iverius P, Pritchard H, Wilson DE. Acute dyslipoproteinemia induced by interleukin-2: Lecithin: cholesteryl aceltransferase, lipoprotein lipase, and hepatic lipase deficiencies. J Clinl Endocr Metab. 1997;82:1572-1581.
16. Applied Research Ethics National Association/Office of Laboratory Animal Welfare. Institutional Animal Care and Use Committee Guidebook. 2nd ed. Bethesda, MD: National Institutes of Health; 2002.
17. Yorganci K, Sayek I, Ismailoglu B, Sahin-Erdemli I. Detrimental effect of nitric oxide on mesenteric circulation during endotoxaemia and its reversal with aminoguanidine. Eur J Surg. 2000;166:888-893.
18. Baykal A, Kaynaroglu V, Hascelik G, Sayek I, Sanac Y. Epinephrine and endotoxin tolerance differentially modulate serum cytokine levels to high-dose lipopolysaccharide challenge in a murine model. Surgery. 1999;125:403-410.
19. Rola-Pleszcynski M, Hensen SA, Vincent MM. Bellanti JA. Inhibitory effects of bilirubin on cellular immune responses in man. J Pediatr. 1975;42:690-696.
20. Rubaltelli FF, Granati B, Fortunato A, Piovesan A, Casara G, Colleselli P, Semenzato G. Inhibitory effects of bilirubin and photobilirubin on neonatal and adult T lymphocytes and granulocytes. Biol Neonate. 1982;42:152-158.
21. Fargion SR, Podda M, Cappellini MD, Fiorelli G. Cellular immunity in intra- and extra-hepatic cholestasis. Minerva Gastroenterol. 1976;22:261-265.
22. Scott-Conner CE, Grogan JB. Serum and cellular factors in murine obstructive jaundice. Surgery. 1994;15:77-84.
23. Roughneen PT, Drath DB, Kulkarni AD. Impaired nonspecific cellular immunity in experimental cholestasis. Ann Surg. 1987;206:578-582.
24. Roughneen PT, Gouma DJ, Kulkarni AD, Fanslow WF, Rowlands BJ. Impaired cell mediated immunity in experimental biliary obstruction. J Surg Res. 1986;41:113-125.
25. Roughneen PT, Gouma DJ, Kulkarni AD, Fanslow WF, Rowlands BJ. Suppression of host versus graft response in experimental biliary obstruction. Transplantation. 1986;42:687-689.
26. Tanaka N, Ryden S, Bergqvist L, Christensen P, Bengmark S. Reticulo-endothelial function in rats with obstructive jaundice. Br J Surg. 1985;72:946-949.
27. Anand AC, Irshad M, Acharya SK, Gandhi BM, Joshi YK, Tandon BN. Fibronectin in acute and subacute hepatic failure. J Clin Gastroenterol. 1989;11:314-319.
28. Wyke RJ, Rajkovich IA, Eddleson AL, Williams R. Defective opsonization and complement deficiency in serum from patients with fulminant hepatic failure. Gut. 1980;21:643-649.
29. Welsh FKS, Ramsden CW, MacLennan K, Sheridan MB, Barclay GR, Guillou PJ, Reynolds JV. Increased intestinal permeability and altered mucosal immunity in cholestatic jaundice. Ann Surg. 1998;227:205-212.
30. Dinarello CA. Proinflammatory cytokines. Chest. 2000;118:503-508.
31. Kimmings AN, Deventer SJ, Rauws EAJ, Huibregste K, Gouma DJ. Systemic inflammatory response in acute cholangitis and after subsequent treatment. Eur J Surg. 2000;166:700-705.
32. Bemelmans MH, Greve JW, Gouma DJ, Buurman WA. Increased concentrations of tumour necrosis factor (TNF) and soluble TNF receptors in biliary obstruction in mice; Soluble TNF receptors as prognostic factors for mortality. Gut. 1996;38:447-453.
33. Fink MP. The role of cytokines as mediators of the inflammatory response. In: Townsend CM, ed., Sabiston Textbook of Surgery. 16th ed. Philadelphia: W. B. Saunders; 2001:28-43.
34. Niedhardt R, Keel M, Steckholzer U, Safret A, Ungethuem U, Trentz O, Ertel W. Relationship of interleukin-10 plasma levels to severity of injury and clinical outcome in injured patients. J Trauma. 1997;42:863-870.
35. Sherry RM, Cue JI, Goddard JK, Parramore JB, DiPiro JT. Interleukin-10 is associated with the development of sepsis in trauma patients. J Trauma. 1996;40:613-616.
36. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001;19:683-765.
37. Taga K, Tosato G. IL-10 inhibits T cell proliferation and IL-2 production. J Immunol. 1992;148:1143-1148.
38. Lin E, Lowry SF, Calvano SE. The systemic response to injury. In: Schwartz SI, ed., Principles of Surgery. 7th ed. New York: McGraw-Hill; 1999:3-51.
39. Wahl SM, McCartney-Francis N, Hunt DA, Smith PD, Wahl LM, Katona IM. Monocyte interleukin receptor gene expression and interleukin 2 augmentation of microbicidal activity. J Immunol. 1987;139:1342-1347.